Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01829191 · ClinicalTrials.gov registry record · NA

Controlling Myopia Progression With Soft Contact Lenses (Contact Lens Control)

A NA study of Myopia, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
174
Enrollment target
1
Study location

NCT01829191 is a NA study of Myopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 174 participants, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01829191, a NA study of Myopia, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
174 participants
Enrollment target
1
Study location

Study Summary

This study is to investigate whether novel soft contact lens optical designs can slow myopia progression

Conditions Studied

Myopia

Interventions

  • DEVICE Soft Contact Test Lens A
  • DEVICE Soft Contact Test Lens C

Study Locations (1)

Massachusetts

  • - Boston

Trial Details

FieldValue
Enrollment Target 174 participants
Start Date 2008-04-01
Est. Completion 2010-05-01
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01829191

The ClinicalTrials.gov registry entry for NCT01829191 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (35% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Soft Contact Test Lens A is the first listed.

NCT01829191 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01829191 about?

NCT01829191 is a clinical study titled "Controlling Myopia Progression With Soft Contact Lenses (Contact Lens Control)". This study is to investigate whether novel soft contact lens optical designs can slow myopia progression

What is the current status of trial NCT01829191?

This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2008-04-01. Estimated completion is 2010-05-01.

What conditions does trial NCT01829191 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT01829191?

The interventions under investigation include: Soft Contact Test Lens A (DEVICE), Soft Contact Test Lens C (DEVICE).

Who is sponsoring clinical trial NCT01829191?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01829191 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myopia

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.